Lunai Bioworks (LNAI) Exchange Rate Effect (2013 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Exchange Rate Effect of -$13029.0 in Q1 2026, down 21.63% quarter-over-quarter from -$10712.0 in Q4 2025, and up 38.45% on a YoY basis from -$9410.8 in Q1 2025.
Lunai Bioworks (LNAI) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Lunai Bioworks' Exchange Rate Effect history runs 14 years deep, the most recent figure standing at -$13029.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 38.45% year-over-year to -$13029.0; the TTM figure through Mar 2026 stood at -$192492.0 (down 192.66% YoY), while the FY2025 annual figure was -$135892.0, down 325.96% from the prior year.
- Exchange Rate Effect was -$13029.0 for Q1 2026 at Lunai Bioworks, down from -$10712.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $153078.0 in Q1 2024 to a low of -$161912.0 in Q2 2025.
- Historically, Exchange Rate Effect has averaged -$6766.4 across 5 years, with a median of -$6839.0 in 2025.
- The sharpest annual moves came in 2022 and 2023: Exchange Rate Effect jumped 3707.24% in 2022, then plunged 3638.57% in 2023.
- A 5-year view of Exchange Rate Effect shows it stood at $22082.0 in 2022, then jumped by 251.41% to $77598.0 in 2023, then fell by 22.76% to $59938.0 in 2024, then plunged by 117.87% to -$10712.0 in 2025, then retreated by 21.63% to -$13029.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$13029.0 (Q1 2026), -$10712.0 (Q4 2025), and -$6839.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | -13,029.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,029.00 |
| Mar 31, 2026 | -13,029.00 |
| Dec 31, 2025 | -10,712.00 |
| Dec 31, 2025 | -10,712.00 |
| Sep 30, 2025 | -6,839.00 |
| Sep 30, 2025 | -6,839.00 |
| Jun 30, 2025 | -161,912.00 |
| Jun 30, 2025 | -161,912.00 |
| Mar 31, 2025 | -21,167.00 |
| Mar 31, 2025 | -21,167.00 |
| Dec 31, 2024 | 59,938.00 |
| Dec 31, 2024 | 59,938.00 |
| Sep 30, 2024 | -12,751.00 |
| Sep 30, 2024 | -12,751.00 |
| Jun 30, 2024 | -91,794.00 |
| Jun 30, 2024 | -91,794.00 |
| Mar 31, 2024 | 153,078.00 |
| Mar 31, 2024 | 153,078.00 |
| Dec 31, 2023 | 77,598.00 |
| Dec 31, 2023 | 77,598.00 |